comparemela.com

Latest Breaking News On - News ratings for fennec pharmaceuticals daily - Page 7 : comparemela.com

HC Wainwright Cuts Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its target price lowered by HC Wainwright from $18.00 to $17.00 in a research note released on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave the […]

United-states
Robert-andrade
Gendell-jeffrey
Chrisa-rallis
Nasdaq
Hartford-financial-management-inc
Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals
Trellus-management-company
Opaleye-management-inc
Cantor-fitzgerald
Fennec-pharmaceuticals-trading

HC Wainwright Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $17.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave […]

United-states
Chrisa-rallis
Robert-andrade
Opaleye-management-inc
Analyst-recommendations-for-fennec-pharmaceuticals
Fennec-pharmaceuticals-stock
Harbert-fund-advisors-inc
Securities-exchange-commission
Fennec-pharmaceuticals
Cantor-fitzgerald
News-ratings-for-fennec-pharmaceuticals-daily
Dg-capital-management

Fennec Pharmaceuticals (FENC) Scheduled to Post Quarterly Earnings on Thursday

Fennec Pharmaceuticals (FENC) Scheduled to Post Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Chrisa-rallis
Robert-andrade
Earnings-history-for-fennec-pharmaceuticals
Fennec-pharmaceuticals-stock-performance
Citigroup-inc
Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals
Barclays-plc
Securities-exchange-commission
Hedge-funds-weigh-in-on-fennec-pharmaceuticals
Jpmorgan-chase-co

Fennec Pharmaceuticals (FENC) to Release Quarterly Earnings on Thursday

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Fennec Pharmaceuticals (NASDAQ:FENC – […]

United-states
America
Chrisa-rallis
Robert-andrade
Earnings-history-for-fennec-pharmaceuticals
Fennec-pharmaceuticals-price-performance
Cantor-fitzgerald
Securities-exchange-commission
Institutional-trading-of-fennec-pharmaceuticals
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals
Boothbay-fund-management

Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below 50-Day Moving Average of $11.34

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$11.34 and traded as low as C$11.27. Fennec Pharmaceuticals shares last traded at C$11.27, with a volume of 100 shares trading hands. Fennec Pharmaceuticals Stock […]

Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals-company-profile
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals-stock-performance
Fennec-pharmaceuticals
Get-free-report
Pharmaceuticals-inc
Fennec-pharmaceuticals-daily
Tse-frx
Frx
Medical

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.